XTL Biopharmaceuticals acquires 85% stake in NeuroNOS for autism therapeutics
Go back to XTL Biopharmaceuticals acquires 85% stake in NeuroNOS for autism therapeutics| (NASDAQ: XAIR) | Delayed: 5.04 -0.12 (2.33%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.16 | 52 Week High | $ | |||
| Open | $5.30 | 52 Week Low | $ | |||
| Day High | $5.31 | P/E | N/A | |||
| Day Low | $4.88 | EPS | $ | |||
| Volume | 23,907 | |||||
| XTL BIOPHARM SP ADR (NASDAQ: XTLB) | Delayed: 2.78 +0.02 (0.72%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.76 | 52 Week High | $1.75 | |||
| Open | $2.78 | 52 Week Low | $0.64 | |||
| Day High | $2.78 | P/E | N/A | |||
| Day Low | $2.78 | EPS | $0.00 | |||
| Volume | 520 | |||||
